Clinical Trials Browser

Phase EARLY_PHASE1 × toripalimab × 1 year × Clear all

NCT06577532 2025-05-21

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms